On the verge of the market - Plant factories for the automated and standardized production of biopharmaceuticals
{{output}}
The market for biopharmaceuticals is dominated by recombinant proteins and is driven mainly by the development of vaccines and antibodies. Manufacturing predominantly relies on fermentation-based production platforms, which have limited scalability and suffer ... ...
